Report cover image

Attention Deficit Hyperactivity Disorder (ADHD) Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 119 Pages
SKU # APRC20351781

Description

Summary

According to APO Research, The global Attention Deficit Hyperactivity Disorder (ADHD) market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Attention Deficit Hyperactivity Disorder (ADHD) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Attention Deficit Hyperactivity Disorder (ADHD) include Amneal Pharmaceuticals, Mallinckrodt, Neos Therapeutics, Noven Pharmaceuticals, Purdue Parma, Tris Pharma, CTFH, Eli Lilly and Novartis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder (ADHD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD).
The Attention Deficit Hyperactivity Disorder (ADHD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Attention Deficit Hyperactivity Disorder (ADHD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Attention Deficit Hyperactivity Disorder (ADHD) Segment by Company

Amneal Pharmaceuticals
Mallinckrodt
Neos Therapeutics
Noven Pharmaceuticals
Purdue Parma
Tris Pharma
CTFH
Eli Lilly
Novartis
Johnson & Johnson
Takeda
Attention Deficit Hyperactivity Disorder (ADHD) Segment by Type

Stimulant
Non-stimulant
Attention Deficit Hyperactivity Disorder (ADHD) Segment by Application

Hospital Pharmacy
Retail Pharmacy
Attention Deficit Hyperactivity Disorder (ADHD) Segment by Application

Hospital Pharmacy
Retail Pharmacy
Attention Deficit Hyperactivity Disorder (ADHD) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Attention Deficit Hyperactivity Disorder (ADHD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Attention Deficit Hyperactivity Disorder (ADHD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Attention Deficit Hyperactivity Disorder (ADHD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

119 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Attention Deficit Hyperactivity Disorder (ADHD) by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Stimulant
2.2.3 Non-stimulant
2.3 Attention Deficit Hyperactivity Disorder (ADHD) by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospital Pharmacy
2.3.3 Retail Pharmacy
2.4 Assumptions and Limitations
3 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Type
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Type (2020-2025)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Type (2026-2031)
4 Attention Deficit Hyperactivity Disorder (ADHD) Breakdown Data by Application
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Application (2020-2025)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Perspective (2020-2031)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Growth Trends by Region
5.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Historic Market Size by Region (2020-2025)
5.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Forecasted Market Size by Region (2026-2031)
5.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Dynamics
5.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends
5.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
5.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges
5.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue
6.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (2020-2025)
6.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2020-2025)
6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Head Office and Area Served
6.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Players, Product Type & Application
6.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Manufacturers Established Date
6.6 Global Attention Deficit Hyperactivity Disorder (ADHD) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2020-2031)
7.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
7.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2020-2031)
8.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
8.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2020-2031)
9.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
9.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2020-2031)
10.2 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
10.4 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2020-2031)
11.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
11.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Amneal Pharmaceuticals
12.1.1 Amneal Pharmaceuticals Company Information
12.1.2 Amneal Pharmaceuticals Business Overview
12.1.3 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.1.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.1.5 Amneal Pharmaceuticals Recent Developments
12.2 Mallinckrodt
12.2.1 Mallinckrodt Company Information
12.2.2 Mallinckrodt Business Overview
12.2.3 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.2.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.2.5 Mallinckrodt Recent Developments
12.3 Neos Therapeutics
12.3.1 Neos Therapeutics Company Information
12.3.2 Neos Therapeutics Business Overview
12.3.3 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.3.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.3.5 Neos Therapeutics Recent Developments
12.4 Noven Pharmaceuticals
12.4.1 Noven Pharmaceuticals Company Information
12.4.2 Noven Pharmaceuticals Business Overview
12.4.3 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.4.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.4.5 Noven Pharmaceuticals Recent Developments
12.5 Purdue Parma
12.5.1 Purdue Parma Company Information
12.5.2 Purdue Parma Business Overview
12.5.3 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.5.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.5.5 Purdue Parma Recent Developments
12.6 Tris Pharma
12.6.1 Tris Pharma Company Information
12.6.2 Tris Pharma Business Overview
12.6.3 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.6.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.6.5 Tris Pharma Recent Developments
12.7 CTFH
12.7.1 CTFH Company Information
12.7.2 CTFH Business Overview
12.7.3 CTFH Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.7.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.7.5 CTFH Recent Developments
12.8 Eli Lilly
12.8.1 Eli Lilly Company Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.8.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.8.5 Eli Lilly Recent Developments
12.9 Novartis
12.9.1 Novartis Company Information
12.9.2 Novartis Business Overview
12.9.3 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.9.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.9.5 Novartis Recent Developments
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Information
12.10.2 Johnson & Johnson Business Overview
12.10.3 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.10.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.10.5 Johnson & Johnson Recent Developments
12.11 Takeda
12.11.1 Takeda Company Information
12.11.2 Takeda Business Overview
12.11.3 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Business (2020-2025)
12.11.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product Portfolio
12.11.5 Takeda Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.